Zobrazeno 1 - 10
of 19 624
pro vyhledávání: '"Adverse event"'
Autor:
Rachel I. Dijkstra-Eijkemans, Linda J. Knap, Nieke A. Elbers, Roland D. Friele, Antony Pemberton
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Over the last decade attention has grown to give patients and next of kin (P/N) more substantial roles in adverse event investigations. Adverse event investigations occur after adverse events that resulted in death or severe injur
Externí odkaz:
https://doaj.org/article/7469b1a7f5904da19cab239e76b2bf9b
Autor:
Takahisa Niimoto, Takafumi Todaka, Hirofumi Kimura, Shotaro Suzuki, Shumpei Yoshino, Kosuke Hoashi, Hirotaka Yamaguchi
Publikováno v:
International Journal of Emergency Medicine, Vol 17, Iss 1, Pp 1-10 (2024)
Abstract Background Cytokine release syndrome (CRS) is an acute systemic inflammatory syndrome characterized by fever and multiple organ failure, which is triggered by immunotherapy or certain infections. Immune checkpoint inhibitors rarely cause imm
Externí odkaz:
https://doaj.org/article/7455da7d0bef4278a6051207694f8e5c
Autor:
Seong Kyung Kim, Myeong Gyu Kim
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract This study aimed to evaluate the association between sacubitril/valsartan and dementia-related adverse events (AEs) in geographical subpopulations using subgroup disproportionality analysis. Cases from the FDA adverse event reporting system
Externí odkaz:
https://doaj.org/article/31541ee1e2c540899c7ba7d8915116f0
Publikováno v:
Prizren Social Science Journal, Vol 8, Iss 2, Pp 63-71 (2024)
This study was designed to investigate patient falls in a university hospital within the scope of patient safety according to variables such as age, gender, time interval when the fall occurred, clinic/polyclinic etc. where the fall occurred and the
Externí odkaz:
https://doaj.org/article/e2318b74243e496885682f7575e0ca08
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 966-972 (2024)
Introduction: Immune-related adverse events (irAEs) from nivolumab can affect any organ, but renal impairment is less common than effects on other organs. We encountered a case in which a renal irAE was difficult to diagnose due to mild renal dysfunc
Externí odkaz:
https://doaj.org/article/dbc979ba0f524722bd33649ea400481f
Autor:
Marina A. Lyadova, Denis S. Fedorinov, Julia S. Mansurova, Evgeniya S. Kuzmina, Yury S. Esakov, Konstantin V. Lyadov, Vsevolod N. Galkin, Irina V. Poddubnaya
Publikováno v:
Consilium Medicum, Vol 26, Iss 6, Pp 362-367 (2024)
Background. Small cell lung cancer (SCLC), predominantly due to smoking, is a highly differentiated, rapidly growing epithelial cell carcinoma of high malignancy originating from bronchial neuroendocrine cells. Almost 70% of SCLC patients have metast
Externí odkaz:
https://doaj.org/article/adc860db45b147ad9c70a80293786c03
Publikováno v:
Oncology and Therapy, Vol 12, Iss 3, Pp 609-620 (2024)
Abstract Apalutamide is a selective androgen receptor signalling inhibitor that is used in the treatment of prostate cancer. Skin rash is one of the most common adverse events with apalutamide. Although the majority of rash events are grade 1 and 2,
Externí odkaz:
https://doaj.org/article/127c164f6eac4c2a9053f0823c49889d
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Trastuzumab emtansine (T-DM1) is widely utilized as a second-line and subsequent treatment for metastatic HER2+ breast cancer and has shown promise in early breast cancer treatment, particularly in adjuvant settings for residual disease afte
Externí odkaz:
https://doaj.org/article/cf8ea2b8612645708a91c061907a0d54
Autor:
Akira Sugimoto, Hiroyasu Kaneda, Naoki Yoshimoto, Kenji Nagata, Tatsuo Fujii, Koichi Michimoto, Shunsuke Ueno, Takao Kamimori, Yoshie Ishii, Mai Sakagami, Haruo Inokuchi, Keiko Shibuya, Megumi Mizutani, Hiroaki Nagamine, Kenji Nakahama, Yoshiya Matsumoto, Yoko Tani, Kenji Sawa, Tomoya Kawaguchi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract The usefulness of the derived neutrophil-to-lymphocyte ratio (dNLR) and its dynamics before/after durvalumab consolidation therapy to predict safety or efficacy remains unclear. We retrospectively reviewed patients with locally advanced non-
Externí odkaz:
https://doaj.org/article/a1e3dc2e879d4326860faa2cdb518933
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Adverse events (AEs) are a significant concern for healthcare systems. However, it is difficult to evaluate their influence because of the complexity of various medical services. This study aimed to assess the influence of AEs on the outcome
Externí odkaz:
https://doaj.org/article/e8ca7aed9ef54a6eb305c2cc9c59524d